0001209191-19-004242.txt : 20190117 0001209191-19-004242.hdr.sgml : 20190117 20190117164918 ACCESSION NUMBER: 0001209191-19-004242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190115 FILED AS OF DATE: 20190117 DATE AS OF CHANGE: 20190117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mohideen Pharis CENTRAL INDEX KEY: 0001760395 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 19531390 MAIL ADDRESS: STREET 1: C/O OVASCIENCE, INC. STREET 2: 9 FOURTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 NORTH MAIN STREET, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: 734-845-9000 MAIL ADDRESS: STREET 1: 301 NORTH MAIN STREET, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-15 0 0001544227 Millendo Therapeutics, Inc. MLND 0001760395 Mohideen Pharis C/O MILLENDO THERAPEUTICS, INC. 301 N. MAIN ST., SUITE 100 ANN ARBOR MI 48104 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 8.80 2019-01-15 4 A 0 64000 0.00 A 2029-01-14 Common Stock 64000 64000 D Twenty-five percent (25%) of the shares subject to this option shall vest on January 15, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Jeffery M. Brinza, Attorney-in-Fact 2019-01-17